Elite Pharmaceuticals INC /NV/ (ELTP) — 8-K Filings

8-K Filings (17)

• Elite Pharmaceuticals Files 8-K — Apr 2, 2026 Risk: low
  Elite Pharmaceuticals Inc. filed an 8-K on April 2, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits)
• Elite Pharmaceuticals Files 8-K — Nov 10, 2025 Risk: low
  Elite Pharmaceuticals Inc. filed an 8-K on November 10, 2025, reporting information under Regulation FD and including financial statements and exhibits. The com
• Elite Pharmaceuticals Files 8-K on Financials — Aug 14, 2025 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on August 14, 2025, reporting on its Results of Operations and Financial Condition. The filing also included Regulation
• Elite Pharmaceuticals Files 8-K with Financials and Exhibits — Aug 8, 2025 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on August 8, 2025, reporting on events that occurred on the same date. The filing primarily concerns financial statemen
• Elite Pharmaceuticals Files 8-K — Jun 23, 2025 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on June 23, 2025, reporting on events that occurred on the same date. The filing primarily concerns financial statement
• Elite Pharmaceuticals Files 8-K — Jun 16, 2025 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on June 16, 2025, reporting under Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not c
• Elite Pharmaceuticals Files 8-K — Apr 30, 2025 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on April 30, 2025, reporting on financial statements and exhibits. The company, incorporated in Nevada with its princip
• Elite Pharmaceuticals Files 8-K — Mar 3, 2025 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on March 3, 2025, reporting events as of February 28, 2025. The filing primarily concerns Regulation FD Disclosure and
• Elite Pharmaceuticals Files 8-K — Dec 26, 2024 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on December 26, 2024, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The c
• Elite Pharmaceuticals Files 8-K — Dec 2, 2024 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on December 2, 2024, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The co
• Elite Pharmaceuticals Files 8-K — Nov 18, 2024 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on November 18, 2024, reporting information under Regulation FD and including financial statements and exhibits. The fi
• Elite Pharmaceuticals Files 8-K — Oct 10, 2024 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on October 10, 2024, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The fi
• Elite Pharmaceuticals Files 8-K — Oct 7, 2024 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on October 7, 2024, reporting on Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not co
• Elite Pharmaceuticals Files 8-K — Aug 27, 2024 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on August 27, 2024, reporting on financial statements and exhibits. The company, incorporated in Nevada with its princi
• Elite Pharmaceuticals Enters Material Definitive Agreement — Jun 21, 2024 Risk: medium
  Elite Pharmaceuticals, Inc. announced on June 17, 2024, that it entered into a material definitive agreement. The filing does not provide specific details about
• Elite Pharmaceuticals Appoints New Auditor — Jun 5, 2024 Risk: low
  Elite Pharmaceuticals, Inc. announced on June 1, 2024, that it has appointed a new independent registered public accounting firm, Citrin Cooperman & Company, LL
• Elite Pharmaceuticals Files 8-K — May 20, 2024 Risk: low
  Elite Pharmaceuticals, Inc. filed an 8-K on May 20, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contai

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX